Lifitegrast

A novel small molecule integrin antagonist that inhibits T cell-mediated inflammation by blocking the binding of two important cell surface proteins (lymphocyte function-associated antigen 1 and intercellular adhesion molecule 1), thereby reducing the overall inflammatory response .

for the treatment of dry eye